The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
ASAP CRN 2025 RFA Scientific Track, 2026Environmental & Genetic Determinants of Parkinson’s Disease Progression
Study Rationale:
Several genetic and environmental factors determine the risk of developing Parkinson’s disease (PD) and how fast the disease progresses. We have identified 2…
-
ASAP CRN 2025 RFA Scientific Track, 2026Defining Separate Rewarding and Aversive Dopaminergic Circuits and Their Role in Parkinson's Disease Associated Pain
Study Rationale:
Parkinson’s disease (PD) has traditionally been defined by people having trouble moving — walking, standing up, etc., but non-movement related symptoms…
-
ASAP CRN Discovery Fellowship 2025, 2026Identifying Common, Non-Coding Genetic Drivers of Neuroinflammation in Parkinson’s Disease
Study Rationale:
Accumulating evidence supports a link between inflammation and Parkinson’s disease (PD). However, researchers do not fully understand which parts of the immune system are important or…
-
Research Grant, 2026A Patient Reported Outcome Assessment for Patients with Early Parkinson’s Disease
Study Rationale:
There are no validated tools to assess functional changes in people living with PD (PwP) at the earliest clinical stages. Available tools lack sufficient sensitivity…
-
ASAP CRN 2025 RFA Scientific Track, 2026Ventral Tegmental Area Dopamine Neuron Subtype-Specific Roles in Parkinson's Disease-Related Cognitive Symptoms
Study Rationale:
Parkinson’s Disease (PD) patients have difficulty in key components of cognition, such as the ability to estimate time intervals as well as learn from negative…
-
ASAP CRN 2025 RFA Scientific Track, 2026Mitochondrial Surface as a Neuroprotective Signal Integrator in PD
Study Rationale:
Accumulation of damage to the cellular batteries (mitochondria) in the brain is a major driver of PD. Analysis of two genes PINK1 and PARKIN have provided…
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.